Hera News & Events


HIS Mice Provide New Preclinical Model for Human Skin Immunity

Despite the convenience and appeal of oral therapies, the reality [...]

By |May 31st, 2017|

What’s Old is New Again: Chemical Carcinogenesis Models of Cancer

Early cancer research focused primarily on chemical carcinogenesis in rat [...]

By |May 31st, 2017|

Hera Presents at SOT 2017 & AACR 2017 Recap

Hera strives to provide its clients with superior preclinical toxicology [...]

By |April 27th, 2017|

In Vivo Liver Gene Delivery

In Vivo Gene Delivery to the Liver Combining the piggyBac™ [...]

By |April 20th, 2017|

Chimeric Humanized Mouse Models: Understanding Human and Mouse Cell Interactions

Humanized liver mouse models are increasingly being used in preclinical [...]

By |February 28th, 2017|

Transposon Mutagenesis Helps Identify Genes Mediating Drug Resistance in the Treatment of CLL

First time treatment of Chronic Lymphocratic Leukemia (CLL) generally requires [...]

By |February 28th, 2017|

PDX Models of Lung Cancer Closely Mimic Characteristics of Patient Primary Tumors

Despite ongoing research, lung cancers have remained among the most [...]

By |February 28th, 2017|

Rat Provides a More Robust & Convenient Animal Infection Model for Hepatitis E Virus

Hepatitis E virus (HEV) is estimated to cause more than [...]

By |December 21st, 2016|

Hera BioLabs, a KY based contract research lab announces $400K Kentucky SBIR/STTR Matching Funds Grant

Hera BioLabs (“Hera”), a Lexington KY based contract research organization [...]

By |December 14th, 2016|

Transgenic Rats as Research Models Boast Significant Benefits….

Transgenic Rats as Research Models Boast Significant Benefits over Mouse [...]

By |November 30th, 2016|